01.10.2021 • News

Nouryon Starts China Polymers Plant

Nouryon has started production at a new plant in Ningbo, China, for two key intermediates used in the manufacture of polymers and composites. The facility has a capacity of 35,000 t/y for tert-butyl hydroperoxide (TBHP) and tert-butyl alcohol (TBA), and output will serve rising demand in Asia for polymers used in the packaging, paints and coatings, and construction markets.

"Asia is a key region for Nouryon and the Ningbo site plays a pivotal role in achieving our growth targets. The investment in this new facility underlines our strategy of strengthening our presence in attractive high-growth markets,” said Sobers Sethi, senior vice president of emerging markets and China.

Nouryon’s site in Ningbo comprises six plants that manufacture chelating agents, organic peroxides, ethylene amines, cellulose ethers and surfactants. In Asia, Nouryon produces organic peroxides in Ningbo and Tianjin, China; Asa, Japan; and Mahad, India.

On Aug. 31, the former AkzoNobel business announced plans to build a new plant in Asia to produce 15,000-20,000 t/y of its Bermocoll cellulose ethers for paints and coatings. The plant will be located at a site in Southeast Asia expected to be announced during the fourth quarter of this year. Start-up is expected for mid-2024.

Author: Elaine Burridge, Freelance Journalist

Nouryon has started up a new plant in Ningbo, China, for two intermediates used...
Nouryon has started up a new plant in Ningbo, China, for two intermediates used to make polymers and composites. The facility produces 35,000 t/y tert-butyl hydroperoxide and tert-butyl alcohol, meeting rising Asian demand into packaging, paints and coatings, and construction. (c) Nouryon

Company

Logo:

Nouryon

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.